-
CASI To Build GMP Mfg. Site In Wuxi, China
contractpharma
November 18, 2018
CASI Pharmaceuticals has entered into agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Economic Development Zone in Jiangsu Province, China. The Wuxi Huishan Economic Development Zone is a science and technology innovation cen
-
Bedrocan becomes world’s first GMP cannabis producer
cphi-online
November 15, 2018
Following a rigorous inspection by the Dutch Health Care Inspectorate, Bedrocan in the Netherlands has become the world’s first producer of medicinal cannabis to be compliant...
-
Minakem opens new high containment facility for production of the highest class of HPAPI
cphi-online
November 15, 2018
Louvain-la-Neuve, Belgium, June 19, 2018 – Minakem, the CDMO division of Minafin, specialized in custom development and manufacturing of building blocks
-
Innovative Salts for Biopharma
cphi-online
November 15, 2018
Dr. Paul Lohmann GmbH KG is specialized in the manufacturing of salts with exceeding purity that meet the highest standards. German production facilities are GMP and DIN EN ISO 9001:2015
-
Aerie Pharmaceuticals Launches GMP Facility
contractpharma
October 30, 2018
Aerie Pharmaceuticals Launches GMP Facility
-
Ken Cunningham, Chairman of Abzena Limited, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO) following completion of the Acquisition by Welsh, Carson, Anderson & Stowe (WCAS)
biospectrumasia
October 17, 2018
People News Abzena Evotec Corporate Affairs
-
Error Cause Analysis Strategy: Human Error Reduction
NIGEL J SMART PHD
September 11, 2018
With a significant on-going drive towards continuous sustainable improvement in the pharmaceutical industry, causes of errors and implementation of various strategies towards root cause analysis have become high profile on the agenda of informed industry
-
US FDA inspects Lupin’s Tarapur API facility
financialexpress
September 04, 2018
Rules out presence of NDMA impurity in co’s Valsartan, Losartan and Irbesartan APIs
-
Almac Group Launches GMP High Throughput Peptide Manufacturing Service
cphi-online
August 30, 2018
Almac Group, the global contract development and manufacturing organisation, is delighted to announce the successful MHRA registration of its High Throughput GMP Peptide manufacturing facility.
-
New biopharmaceutical testing laboratory to open in Geneva
cphi-online
August 29, 2018
SGS's expansion will enable the service provider to offer a full ICH Q6B physico-chemical characterization of biological products.